Commentary: sorafenib -- the end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2009 AND VI 14 AND IP 1
Results: 21
1
2
Response to 'Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting'.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? [corrected] [published erratum appears in ONCOLOGIST 2009 Mar;14(3):307].
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 95, doi. 10.1634/theoncologist.2008-0185
- By:
- Publication type:
- Article
6
Commentary: Sorafenib--The End of a Long Journey in Search of Systemic Therapy for Hepatocellular Carcinoma, or the Beginning?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
7
The Role of IGF-1R in Pediatric Malignancies.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 83, doi. 10.1634/theoncologist.2008-0189
- By:
- Publication type:
- Article
8
Commentary: Disclosure in Oncology--To Whom Does the Truth Belong?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
9
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 70, doi. 10.1634/theoncologist.2008-0191
- By:
- Publication type:
- Article
10
Commentary: Sorafenib Use in Patients with Advanced Hepatocellular Carcinoma and Underlying Child-Pugh B Cirrhosis--Evidence and Controversy.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
11
Untangling the Complexities of Depression Diagnosis in Older Cancer Patients.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 60, doi. 10.1634/theoncologist.2008-0147
- By:
- Publication type:
- Article
12
Cytoreductive Nephrectomy in Metastatic Clear-Cell Renal Cell Carcinoma: Perspectives in the Tyrosine Kinase Inhibitor Era.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 52, doi. 10.1634/theoncologist.2008-0121
- By:
- Publication type:
- Article
13
Indications, Extent, and Benefits of Pelvic Lymph Node Dissection for Patients with Bladder and Prostate Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 40, doi. 10.1634/theoncologist.2008-0123
- By:
- Publication type:
- Article
14
Anti-Epidermal Growth Factor Receptor Monotherapy in the Treatment of Metastatic Colorectal Cancer: Where Are We Today?
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 29, doi. 10.1634/theoncologist.2008-0167
- By:
- Publication type:
- Article
15
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 22, doi. 10.1634/theoncologist.2008-0213
- By:
- Publication type:
- Article
16
Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 12, doi. 10.1634/theoncologist.2008-0132
- By:
- Publication type:
- Article
17
Response to "Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting.".
- Published in:
- 2009
- By:
- Publication type:
- Letter
18
Response to "Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting.".
- Published in:
- 2009
- By:
- Publication type:
- Letter
19
Epidemiologic Studies Are Needed To Clarify Whether Dental Modalities Could Be Predictors of Bisphosphonate Osteonecrosis of the Jaw in Breast Cancer Patients.
- Published in:
- 2009
- By:
- Publication type:
- Letter
20
Epidemiologic Studies Are Needed To Clarify Whether Dental Modalities Could Be Predictors of Bisphosphonate Osteonecrosis of the Jaw in Breast Cancer Patients.
- Published in:
- 2009
- By:
- Publication type:
- Letter
21
Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 1, doi. 10.1634/theoncologist.2008-0137
- By:
- Publication type:
- Article